Allworth Financial’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$462K Buy
3,033
+751
+33% +$125K ﹤0.01% 1015
2026
Q1
$479K Buy
2,282
+1,886
+476% +$474K ﹤0.01% 969
2025
Q4
$113K Sell
396
-6
-1% -$1.88K ﹤0.01% 1676
2025
Q3
$124K Buy
402
+57
+17% +$17.9K ﹤0.01% 1558
2025
Q2
$108K Buy
345
+8
+2% +$2.31K ﹤0.01% 1496
2025
Q1
$87.3K Sell
337
-24
-7% -$6.5K ﹤0.01% 1293
2024
Q4
$101K Sell
361
-56
-13% -$14.1K ﹤0.01% 1265
2024
Q3
$96.9K Sell
417
-10
-2% -$2.05K ﹤0.01% 1101
2024
Q2
$83.2K Buy
427
+132
+45% +$23.8K ﹤0.01% 1144
2024
Q1
$50.6K Buy
295
+71
+32% +$13.2K ﹤0.01% 1303
2023
Q4
$48.6K Buy
224
+44
+24% +$7.55K ﹤0.01% 1216
2023
Q3
$28.7K Buy
180
+92
+105% +$20.6K ﹤0.01% 1331
2023
Q2
$25.4K Sell
88
-2
-2% -$607 ﹤0.01% 1398
2023
Q1
$28.7K Buy
90
+2
+2% +$593 ﹤0.01% 1276
2022
Q4
$25.9K Buy
88
+55
+167% +$15.2K ﹤0.01% 1244
2022
Q3
$8K Sell
33
-244
-88% -$61.1K ﹤0.01% 1755
2022
Q2
$60K Buy
277
+269
+3,363% +$61.1K ﹤0.01% 844
2022
Q1
$2K Buy
+8
New +$1.96K ﹤0.01% 1816

Other funds holding PODD

Allworth Financial's PODD Position: Q2 2026 in Review

Allworth Financial increased its Insulet (PODD) stake by 33% in Q2 2026, buying an estimated $125K and bringing the position to 3,033 shares worth $462K. The position accounts for ﹤0.01% of the portfolio, ranked #1015.

Allworth Financial first reported a position in PODD in Q1 2022 and has held it in 18 quarters since. The position peaked at $479K in Q1 2026. 722 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Allworth Financial held 3,033 shares of Insulet worth $462K as of Q2 2026.
  • Allworth Financial bought 751 Insulet shares in Q2 2026, an estimated $125K.
  • Insulet made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #1015 holding.
  • Allworth Financial first reported a position in Insulet in Q1 2022 and has held it in 18 quarters since.
  • Allworth Financial's Insulet position peaked at $479K in Q1 2026.
  • 722 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.